June 2025
Calibre Scientific welcomes William Kullback as Chief Financial Officer
In his new role at CSG, Kullback oversees the company’s global finance organization, including financial planning and analysis, accounting, investor relations, treasury tax, IT, and procurement.
Siddhartha Kadia, CEO of Calibre Scientific, said, “We’re thrilled to have William on our team. His extensive experience and deep expertise in our industry will be instrumental as the company grows, innovates, and continues delivering exceptional value to our customers worldwide.”
Kullback brings more than 30 years of finance and executive leadership experience, including multiple public company CFO roles in the medical device and life science sectors. He most recently served as CFO of Telesis Bio and previously led BioLegend through a $5.25B acquisition by Perkin Elmer—the largest in their history.